share_log

Investors in Tenet Healthcare (NYSE:THC) Have Seen Incredible Returns of 691% Over the Past Five Years

Investors in Tenet Healthcare (NYSE:THC) Have Seen Incredible Returns of 691% Over the Past Five Years

泰尼特醫療(紐交所:THC)的投資者在過去五年中獲得了令人難以置信的回報率,高達691%。
Simply Wall St ·  08/29 18:18

Buying shares in the best businesses can build meaningful wealth for you and your family. And highest quality companies can see their share prices grow by huge amounts. Don't believe it? Then look at the Tenet Healthcare Corporation (NYSE:THC) share price. It's 691% higher than it was five years ago. And this is just one example of the epic gains achieved by some long term investors. It's also good to see the share price up 22% over the last quarter. We love happy stories like this one. The company should be really proud of that performance!

購買最好的企業股票可以爲您和您的家人積累重要的財富。高質量的公司的股價有可能大幅增長。不相信嗎?那就看看泰尼特(Tenet Healthcare Corporation)(紐交所:THC)的股票價格吧。它比五年前高出了691%。這只是長期投資者取得的巨大收益的一個例子。過去一個季度,股價上漲了22%,這也令人高興。我們喜歡這樣的成功故事。公司應該爲這樣的業績感到驕傲!

So let's assess the underlying fundamentals over the last 5 years and see if they've moved in lock-step with shareholder returns.

因此,讓我們評估過去5年的基本面,看看它們是否和股東的回報率相符。

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

雖然一些人仍然相信有效市場假說,但已經證明市場是過度反應的動態系統,投資者並不總是理性的。一個不完美但簡單的方法來考慮公司市場看法的變化是比較每股收益(EPS)的變化和股價的波動。

During the last half decade, Tenet Healthcare became profitable. Sometimes, the start of profitability is a major inflection point that can signal fast earnings growth to come, which in turn justifies very strong share price gains. Given that the company made a profit three years ago, but not five years ago, it is worth looking at the share price returns over the last three years, too. We can see that the Tenet Healthcare share price is up 117% in the last three years. In the same period, EPS is up 91% per year. This EPS growth is higher than the 30% average annual increase in the share price over the same three years. Therefore, it seems the market has moderated its expectations for growth, somewhat. This cautious sentiment is reflected in its (fairly low) P/E ratio of 5.66.

在過去的半個十年裏,泰尼特醫療保健開始盈利。有時,盈利的開始是一個重要的拐點,會預示着快速盈利增長,從而合理地推動股價大幅上漲。考慮到公司三年前開始盈利,但五年前還未盈利,值得關注股價在過去三年的回報。我們可以看到,泰尼特醫療保健的股價在過去三年中上漲了117%。在同一期間,每股收益年均增長91%。這種每股收益的增長高於相同三年期股價的30%平均年增長率。因此,市場對增長的預期已經稍稍調整。這種謹慎的情緒反映在其相對較低的市盈率(5.66)中。

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

您可以在下面的圖片中查看每股收益如何隨時間變化(單擊圖表以查看確切的價值)。

1724926683618
NYSE:THC Earnings Per Share Growth August 29th 2024
2024年8月29日紐交所:泰尼特每股收益增長

We know that Tenet Healthcare has improved its bottom line over the last three years, but what does the future have in store? This free interactive report on Tenet Healthcare's balance sheet strength is a great place to start, if you want to investigate the stock further.

我們知道泰尼特醫療在過去三年裏改善了其底線,但未來會如何呢?如果您想進一步研究這支股票,泰尼特醫療的資產負債表力量的這份免費互動報告是一個很好的起點。

A Different Perspective

不同的觀點

It's nice to see that Tenet Healthcare shareholders have received a total shareholder return of 108% over the last year. That's better than the annualised return of 51% over half a decade, implying that the company is doing better recently. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Consider for instance, the ever-present spectre of investment risk. We've identified 4 warning signs with Tenet Healthcare (at least 1 which makes us a bit uncomfortable) , and understanding them should be part of your investment process.

很高興看到泰尼特醫療股東在過去一年裏獲得了總股東回報率爲108%。這比過去半個十年的年化回報率51%要好,這意味着公司的近期表現更好。鑑於股價動力仍然強勁,值得更加密切地關注這支股票,以免錯過機會。對我來說,長期股價作爲業務績效的一種代理是非常有趣的。但要真正獲得洞察力,我們還需要考慮其他信息。比如,常常存在的投資風險威脅。我們已經找出了泰尼特醫療的4個警示信號(至少有1個讓我們感到有些不舒服),了解它們應該成爲您的投資過程的一部分。

If you are like me, then you will not want to miss this free list of undervalued small caps that insiders are buying.

如果您像我一樣,就不會希望錯過這份免費的內部人士正在購買的低估小市值股票列表。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論